论文部分内容阅读
目的分析低分子右旋糖酐发生过敏性休克的规律,从而为患者提供更好的药学监护。方法选取低分子右旋糖酐而引起过敏性休克患者53例资料进行统计分析。结果 53例患者发生过敏性休克,其中>50岁者28例(52.83%),在用药30 min内发生过敏性休克者44例(83.02%),首次用药发生过敏性休克者50例(94.34%),联合注射剂致过敏性休克者14例(26.42%),临床表现以呼吸系统、循环系统症状较多见。结论对使用低分子右旋糖酐的患者应加强药学监护,特别是用药前30 min应特别关注患者病情变化,并尽量避免与其他药物联用,以减少过敏性休克的发生。
Objective To analyze the regularity of hypoallergenic shock in patients with dextran, so as to provide better pharmacy care for patients. Methods The data of 53 patients with atopic shock induced by low molecular weight dextran were statistically analyzed. Results Fifty-three patients developed anaphylactic shock, including 28 (> 52.83%)> 50 years old, 44 (83.02%) patients with anaphylactic shock within 30 minutes, 50 cases (94.34% ), 14 cases (26.42%) of the joint injection induced anaphylactic shock, the clinical manifestations of the respiratory system, circulatory system more common symptoms. Conclusion In patients with low molecular weight dextran, intensive care should be strengthened. In particular, 30 min before treatment should pay special attention to the patient’s condition changes, and try to avoid combined with other drugs to reduce the incidence of anaphylactic shock.